Boric acid inhibits stored Ca2+ release in DU-145 prostate cancer cells
- 31 May 2008
- journal article
- research article
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 25 (4) , 309-320
Abstract
Boron (B) is a developmental and reproductive toxin. It is also essential for some organisms. Plants use uptake and efflux transport proteins to maintain homeostasis, and in humans, boron has been reported to reduce prostate cancer. Ca2+ signaling is one of the primary mechanisms used by cells to respond to their environment. In this paper, we report that boric acid (BA) inhibits NAD+ and NADP+ as well as mechanically induced release of stored Ca2+ in growing DU-145 prostate cancer cells. Cell proliferation was inhibited by 30% at 100μM, 60% at 250μM, and 97% at 1,000μM BA. NAD+-induced Ca2+ transients were partly inhibited at 250μM BA and completely at 1,000μM BA, whereas both NADP+ and mechanically induced transients were inhibited by 1,000μM BA. Expression of CD38 protein increased in proportion to BA exposure (0–1,000μM). In vitro mass spectrometry analysis showed that BA formed adducts with the CD38 products and Ca2+ channel agonists cyclic adenosine diphosphate ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP). Vesicles positive for the Ca2+ fluorophore fluo-3 acetoxymethyl ester accumulated in cells exposed to 250 and 1,000μM BA. The BA analog, methylboronic acid (MBA; 250 and 1,000μM), did not inhibit cell proliferation or NAD+, NADP+, or mechanically stimulated Ca2+ store release. Nor did MBA increase CD38 expression or cause the formation of intracellular vesicles. Thus, mammalian cells can distinguish between BA and its synthetic analog MBA and exhibit graded concentration-dependent responses. Based on these observations, we hypothesize that toxicity of BA stems from the ability of high concentrations to impair Ca2+ signaling.Keywords
This publication has 39 references indexed in Scilit:
- Evaluation of ecological and in vitro effects of boron on prostate cancer risk (United States)Cancer Causes & Control, 2007
- Cellular changes in boric acid-treated DU-145 prostate cancer cellsBritish Journal of Cancer, 2006
- Boric acid inhibits human prostate cancer cell proliferationCancer Letters, 2004
- Store-operated Ca2+ channels in prostate cancer epithelial cells: function, regulation, and role in carcinogenesisCell Calcium, 2003
- Structural identification of a bacterial quorum-sensing signal containing boronNature, 2002
- A Self-restricted CD38-connexin 43 Cross-talk Affects NAD+ and Cyclic ADP-ribose Metabolism and Regulates Intracellular Calcium in 3T3 FibroblastsJournal of Biological Chemistry, 2001
- Boron Supplementation of a Semipurified Diet for Weanling Pigs Improves Feed Efficiency and Bone Strength Characteristics and Alters Plasma Lipid MetabolitesThe Journal of Nutrition, 2000
- The Effects of Dietary Boron on Bone Strength in RatsFundamental and Applied Toxicology, 1997
- Benchmark Dose Analysis of Developmental Toxicity in Rats Exposed to Boric AcidFundamental and Applied Toxicology, 1996
- Proposed physiologic functions of boron in plants pertinent to animal and human metabolism.Environmental Health Perspectives, 1994